Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$37.81 - $52.4 $145,870 - $202,159
3,858 New
3,858 $202,000
Q3 2023

Nov 14, 2023

SELL
$36.46 - $44.03 $4,484 - $5,415
-123 Reduced 1.61%
7,516 $287,000
Q2 2023

Aug 14, 2023

SELL
$30.28 - $38.74 $5,662 - $7,244
-187 Reduced 2.39%
7,639 $275,000
Q1 2023

Aug 14, 2023

BUY
$32.86 - $55.7 $6,144 - $10,415
187 Added 2.45%
7,826 $298,000
Q1 2023

May 15, 2023

SELL
$32.86 - $55.7 $40,549 - $68,733
-1,234 Reduced 13.62%
7,826 $298,000
Q4 2022

Feb 14, 2023

BUY
$40.06 - $59.44 $2,603 - $3,863
65 Added 0.72%
9,060 $515,000
Q3 2022

Nov 14, 2022

SELL
$38.53 - $51.78 $326,464 - $438,731
-8,473 Reduced 48.51%
8,995 $356,000
Q2 2022

Aug 11, 2022

BUY
$37.35 - $48.3 $315,719 - $408,279
8,453 Added 93.77%
17,468 $769,000
Q1 2022

May 16, 2022

BUY
$31.97 - $41.06 $1,598 - $2,053
50 Added 0.56%
9,015 $360,000
Q4 2021

Feb 14, 2022

BUY
$31.82 - $40.75 $159 - $203
5 Added 0.06%
8,965 $360,000
Q3 2021

Nov 15, 2021

SELL
$38.47 - $46.42 $192 - $232
-5 Reduced 0.06%
8,960 $364,000
Q4 2020

Feb 17, 2021

BUY
$25.81 - $43.62 $129 - $218
5 Added 0.06%
8,965 $383,000
Q2 2020

Aug 13, 2020

BUY
$16.25 - $26.81 $145,600 - $240,217
8,960 New
8,960 $240,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.